Entrada (TRDA) Q2 Revenue Drops 98%
Entrada Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $6.91
+25% in 7d after detection
Post-detection moves
1h
—
1d
+6.9%
3d
+16%
7d
+25%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS